| Autophagic degeneration of motor neurons in a model of slow glutamate excitotoxicity in vitro. | |
| | |
MedLine Citation:
|
PMID: 16257859 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is increasing evidence that so-called "autophagic cell death" participates in cell degeneration in certain pathological conditions. Autophagy might be involved in some neurodegenerative processes, including lateral amyotrophic sclerosis (SLA). The exact mechanism leading to progressive motor neuron (MN) loss remains unclear, but glutamate-mediated mechanism is thought to be responsible. Previous ultrastructural studies by the authors performed on a model of SLA in vitro, based on chronic glutamate excitotoxicity, revealed a subset of morphological features characteristic to different modes of neuronal death, including autophagic degeneration. The contribution of this pathway of MNs death is evaluated in organotypic cultures of rat lumbar spinal cord chronically exposed to specific glutamate uptake blockers: DL-threo-beta-hydroxyaspartate (THA) and L-transpyrrolidine-2,4-dicarboxylate (PDC). The study documents the various steps of authophagy in slowly evolving process of MN neurodegeneration. The cells undergoing autophagy usually exhibited sequestration of some parts of cytoplasm with normal and/or degenerated organelles, whereas other parts of cytoplasm as well as neuronal nucleus remained unchanged. The advanced autophagic changes were often associated with other modes of MN death, especially with apoptosis. Numerous MNs revealed apoptotic nuclear features with typical peripheral margination of nuclear chromatin, accompanied by severe autophagic or autophagic-necrotic degeneration of the cytoplasm. These results support the opinion of unclear distinction between different modes of cell death and indicate the involvement of autophagey in MNs neurodegeneration in vitro. |
| | |
Authors:
|
Ewa Matyja; Anna Taraszewska; Ewa Nagańska; Janina Rafałowska |
Related Documents
:
|
12887599 - The allograft inflammatory factor-1 in creutzfeldt-jakob disease brains. 11529499 - The neurotrophic factors in non-neuronal tissues. 11549719 - Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizy... 20553229 - The role of neurotrophins in inflammation and allergy. 17542809 - The organotellurium compound ammonium trichloro(dioxoethylene-0,0') tellurate enhances ... 19243239 - Innate and adaptive immunity for the pathobiology of parkinson's disease. 18501759 - Immunoparalysis and adverse outcomes from critical illness. 10595309 - Signaling through gp130: toward a general scenario of cytokine action. 8573349 - Proteolytic remodeling of extracellular matrix. |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Ultrastructural pathology Volume: 29 ISSN: 0191-3123 ISO Abbreviation: Ultrastruct Pathol Publication Date: 2005 Sep-Oct |
Date Detail:
|
Created Date: 2005-10-31 Completed Date: 2005-12-13 Revised Date: 2009-06-26 |
Medline Journal Info:
|
Nlm Unique ID: 8002867 Medline TA: Ultrastruct Pathol Country: United States |
Other Details:
|
Languages: eng Pagination: 331-9 Citation Subset: IM |
Affiliation:
|
Department of Experimental and Clinical Neuropathology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amyotrophic Lateral Sclerosis
/
pathology Animals Animals, Newborn Apoptosis / drug effects Aspartic Acid / analogs & derivatives, pharmacology Autophagy / drug effects* Dicarboxylic Acids / pharmacology Disease Models, Animal Excitatory Amino Acid Antagonists / pharmacology* Glutamic Acid / metabolism Microscopy, Electron Motor Neurons / drug effects*, ultrastructure Nerve Degeneration* Neurotransmitter Uptake Inhibitors / pharmacology* Organ Culture Techniques Organelles / ultrastructure Pyrrolidines / pharmacology Rats Spinal Cord / drug effects*, pathology, ultrastructure |
| Chemical | |
Reg. No./Substance:
|
0/Dicarboxylic Acids; 0/Excitatory Amino Acid Antagonists; 0/Neurotransmitter Uptake Inhibitors; 0/Pyrrolidines; 1860-87-3/3-hydroxyaspartic acid; 56-84-8/Aspartic Acid; 56-86-0/Glutamic Acid; 99319-03-6/pyrrolidine-2,4-dicarboxylic acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Individual reference intervals of hematological and serum biochemical parameters in cynomolgus monke...
Next Document: The ultrastructure of hybrid acute leukemia: a study of 15 cases.